BCM

BIOS Capital Management Portfolio holdings

AUM $82.6M
1-Year Est. Return 3.89%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+3.89%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$82.6M
AUM Growth
-$6.29M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

1
+$63.2K
2
+$23.1K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACTU
1
Actuate Therapeutics
ACTU
$64.4M
$61.5M 74.44%
10,049,996
CGTX icon
2
Cognition Therapeutics
CGTX
$102M
$8.1M 9.8%
6,000,000
IRD
3
Opus Genetics
IRD
$335M
$7.4M 8.96%
3,683,429
LTRN icon
4
Lantern Pharma
LTRN
$26.1M
$3.06M 3.7%
1,009,507
-6,208
RNTX
5
Rein Therapeutics
RNTX
$37.3M
$1.96M 2.37%
1,690,751
INAB icon
6
IN8bio
INAB
$18.7M
$593K 0.72%
253,417
-33,247